Composition: Calcium Citrate 250mg + Vit. D3 125 IU + Zinc Sul. 25mg + Calcitriol 0.25mcg + Calcium aspartate anhydrous 500mg + Calcium orotate 500mg + Elemental Magnesium 50mg + Elemental zinc 7.5mg + Folic acid 1.5mg + Hydroxy Cobalamin 100mcg
Description
Composition: Calcium Citrate 250mg + Vit. D3 125 IU + Zinc Sul. 25mg + Calcitriol 0.25mcg + Calcium aspartate anhydrous 500mg + Calcium orotate 500mg + Elemental Magnesium 50mg + Elemental zinc 7.5mg + Folic acid 1.5mg + Hydroxy Cobalamin 100mcg [composition under verification] (tablets). In this combination, Calcium (bone mineral), Calcitriol (active vitamin D), Vitamin D3 (vitamin D), Magnesium (essential mineral) and Zinc (trace mineral) are paired so that their mechanisms work alongside one another.
Calcium is the principal mineral of bone. Calcitriol is the active form of vitamin D that promotes calcium absorption. Cholecalciferol (vitamin D3) supports calcium absorption and bone health. Magnesium is required for muscle, nerve and bone function. Zinc is a trace mineral involved in immune function and tissue repair.
CALSITA-FORTE is a prescription medicine from Aerochem Neutron's calcium range, for use on the prescription of a registered medical practitioner.
· Contains Calcium Citrate 250mg + Vit. D3 125 IU + Zinc Sul. 25mg + Calcitriol 0.25mcg + Calcium aspartate anhydrous 500mg + Calcium orotate 500mg + Elemental Magnesium 50mg + Elemental zinc 7.5mg + Folic acid 1.5mg + Hydroxy Cobalamin 100mcg.
· Calcium is the principal mineral of bone
· Calcitriol is the active form of vitamin D that promotes calcium absorption
· Cholecalciferol (vitamin D3) supports calcium absorption and bone health
· Magnesium is required for muscle, nerve and bone function
· Zinc — trace mineral involved in immune function and tissue repair
· Presented as tablets
· Osteoporosis and osteopenia (adjunct)
· Calcium and vitamin D deficiency
· Hypocalcaemia, as directed by a physician
· Note: indications reflect established dietary supplementation of the individual molecules, as per the FSSAI.
Safety
· Contraindicated in patients with known hypersensitivity to any component.
· Monitor serum calcium; avoid in hypercalcaemia and vitamin D toxicity.
· High-dose vitamin D should be used only for confirmed deficiency; monitor for hypercalcaemia.
· Pregnancy and lactation: use only if the prescriber judges the benefit to outweigh the risk.
Clinical Rationale: The mechanisms and labelled uses of calcitriol described here follow the US prescribing information (DailyMed). Evidence summary for Calcium, Vitamin D3, Magnesium, Zinc: reference verification pending.
References
· DailyMed (US NLM) prescribing information – calcitriol: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=CALCITRIOL
· Reference verification pending for: Calcium, Vitamin D3, Magnesium, Zinc
Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.
Review verified active composition, strength, dosage form, and packaging details on this page.
View SpecificationsRequest formulation literature, technical specifications, or product communication from our commercial team.
Submit Product EnquiryConnect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.
Commercial EnquiryThis product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.
Request information about CALSITA FORTE for professional use.